Small EJ - Search Results

1

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

Rathkopf DE, Smith MR, de Bono JS, Logothetis CJ, Shore ND, de Souza P, Fizazi K, Mulders PF, Mainwaring P, Hainsworth JD, Beer TM, North S, Fradet Y, Van Poppel H, Carles J, Flaig TW, Efstathiou E, Yu EY, Higano CS, Taplin ME, Griffin TW, Todd MB, Yu MK, Park YC, Kheoh T, Small EJ, Scher HI, Molina A, Ryan CJ, Saad F. Rathkopf DE, et al. Among authors: small ej. Eur Urol. 2014 Nov;66(5):815-25. doi: 10.1016/j.eururo.2014.02.056. Epub 2014 Mar 6. Eur Urol. 2014. PMID: 24647231 Free PMC article. Clinical Trial.

2

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.

Small EJ, Carroll PR. Small EJ, et al. Urology. 1994 Mar;43(3):408-10. doi: 10.1016/0090-4295(94)90092-2. Urology. 1994. PMID: 7510915

3

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

Roach M 3rd, Meehan S, Kroll S, Weil M, Ryu J, Small EJ, Margolis LW, Presti J, Carroll PC, Phillips TL. Roach M 3rd, et al. Among authors: small ej. J Urol. 1996 Nov;156(5):1719-23. J Urol. 1996. PMID: 8863578 Clinical Trial.

4

Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal.

Small EJ, Baron AD, Fippin L, Apodaca D. Small EJ, et al. J Urol. 1997 Apr;157(4):1204-7. J Urol. 1997. PMID: 9120902 Clinical Trial.

5

Focal therapy for prostate cancer 1996: maximizing outcome.

Carroll PR, Presti JC Jr, Small E, Roach M 3rd. Carroll PR, et al. Urology. 1997 Mar;49(3A Suppl):84-94. doi: 10.1016/s0090-4295(97)00174-x. Urology. 1997. PMID: 9123742 Review.

6

Intermittent androgen deprivation for clinically localized prostate cancer: initial experience.

Grossfeld GD, Small EJ, Carroll PR. Grossfeld GD, et al. Among authors: small ej. Urology. 1998 Jan;51(1):137-44. doi: 10.1016/s0090-4295(97)00488-3. Urology. 1998. PMID: 9457309 Clinical Trial.

7

The treatment of advanced prostate cancer with ketoconazole: safety issues.

Bok RA, Small EJ. Bok RA, et al. Among authors: small ej. Drug Saf. 1999 May;20(5):451-8. doi: 10.2165/00002018-199920050-00005. Drug Saf. 1999. PMID: 10348095 Review.

8

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.

Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, Balk SP. Taplin ME, et al. Among authors: small ej. Cancer Res. 1999 Jun 1;59(11):2511-5. Cancer Res. 1999. PMID: 10363963

9

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Bubley GJ, et al. Among authors: small ej. J Clin Oncol. 1999 Nov;17(11):3461-7. doi: 10.1200/JCO.1999.17.11.3461. J Clin Oncol. 1999. PMID: 10550143

10

Outpatient combination chemoimmunotherapy for patients with metastatic melanoma. Results of a phase I/II trial.

Kashani-Sabet M, Sagebiel RW, Collins HE, Glassberg AB, Allen RE, Leong SP, Small EJ. Kashani-Sabet M, et al. Among authors: small ej. Cancer. 1999 Nov 15;86(10):2160-5. doi: 10.1002/(sici)1097-0142(19991115)86:10<2160::aid-cncr40>3.0.co;2-w. Cancer. 1999. PMID: 10570447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page